Sign in to edit your profile (add interests, mentoring, photo, etc.)
    Keywords
    Last Name
    Institution

    Victor Reus, MD

    TitleProfessor in Residence
    SchoolUCSF School of Medicine
    DepartmentPsychiatry
    Address401 Parnassus Ave, LangPorter
    San Francisco CA 94143
    Phone415-476-7478

       Bibliographic 
       Publications
      Publications by year:
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      1. Nag A, Bochukova EG, Kremeyer B, Campbell DD, Muller H, Valencia-Duarte AV, Cardona J, Rivas IC, Mesa SC, Cuartas M, Garcia J, Bedoya G, Cornejo W, Herrera LD, Romero R, Fournier E, Reus VI, Lowe TL, Farooqi IS. CNV Analysis in Tourette Syndrome Implicates Large Genomic Rearrangements in COL8A1 and NRXN1. PLoS One. 2013; 8(3):e59061.
        View in: PubMed
      2. Chen K, Budman CL, Diego Herrera L, Witkin JE, Weiss NT, Lowe TL, Freimer NB, Reus VI, Mathews CA. Prevalence and clinical correlates of explosive outbursts in Tourette Syndrome. Psychiatry Res. 2013 Feb 28; 205(3):269-75.
        View in: PubMed
      3. Mathews CA, Badner JA, Andresen JM, Sheppard B, Himle JA, Grant JE, Williams KA, Chavira DA, Azzam A, Schwartz M, Reus VI, Kim SW, Cook EH, Hanna GL. Genome-wide linkage analysis of obsessive-compulsive disorder implicates chromosome 1p36. Biol Psychiatry. 2012 Oct 15; 72(8):629-36.
        View in: PubMed
      4. Wolkowitz OM, Wolf J, Shelly W, Rosser R, Burke HM, Lerner GK, Reus VI, Nelson JC, Epel ES, Mellon SH. Serum BDNF levels before treatment predict SSRI response in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15; 35(7):1623-30.
        View in: PubMed
      5. Hall SM, Humfleet GL, Muñoz RF, Reus VI, Prochaska JJ, Robbins JA. Using extended cognitive behavioral treatment and medication to treat dependent smokers. Am J Public Health. 2011 Dec; 101(12):2349-56.
        View in: PubMed
      6. Wolkowitz OM, Mellon SH, Epel ES, Lin J, Dhabhar FS, Su Y, Reus VI, Rosser R, Burke HM, Kupferman E, Compagnone M, Nelson JC, Blackburn EH. Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress--preliminary findings. PLoS One. 2011; 6(3):e17837.
        View in: PubMed
      7. Hatsukami DK, Jorenby DE, Gonzales D, Rigotti NA, Glover ED, Oncken CA, Tashkin DP, Reus VI, Akhavain RC, Fahim RE, Kessler PD, Niknian M, Kalnik MW, Rennard SI. Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic. Clin Pharmacol Ther. 2011 Mar; 89(3):392-9.
        View in: PubMed
      8. Wolkowitz OM, Mellon SH, Epel ES, Lin J, Reus VI, Rosser R, Burke H, Compagnone M, Nelson JC, Dhabhar FS, Blackburn EH. Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response. Mol Psychiatry. 2012 Feb; 17(2):164-72.
        View in: PubMed
      9. Wolkowitz OM, Reus VI, Mellon SH. Of sound mind and body: depression, disease, and accelerated aging. Dialogues Clin Neurosci. 2011; 13(1):25-39.
        View in: PubMed
      10. Faulkner LR, Juul D, Andrade NN, Brooks BA, Colenda CC, Guynn RW, Mrazek DA, Reus VI, Schneidman BS, Shaw KR. Recent trends in american board of psychiatry and neurology psychiatric subspecialties. Acad Psychiatry. 2011 Jan-Feb; 35(1):35-9.
        View in: PubMed
      11. Kremeyer B, García J, Müller H, Burley MW, Herzberg I, Parra MV, Duque C, Vega J, Montoya P, López MC, Bedoya G, Reus V, Palacio C, López C, Ospina-Duque J, Freimer NB, Ruiz-Linares A. Genome-wide linkage scan of bipolar disorder in a Colombian population isolate replicates Loci on chromosomes 7p21-22, 1p31, 16p12 and 21q21-22 and identifies a novel locus on chromosome 12q. Hum Hered. 2010; 70(4):255-68.
        View in: PubMed
      12. Wolkowitz OM, Epel ES, Reus VI, Mellon SH. Depression gets old fast: do stress and depression accelerate cell aging? Depress Anxiety. 2010 Apr; 27(4):327-38.
        View in: PubMed
      13. Jasinska AJ, Service S, Jawaheer D, DeYoung J, Levinson M, Zhang Z, Kremeyer B, Muller H, Aldana I, Garcia J, Restrepo G, Lopez C, Palacio C, Duque C, Parra M, Vega J, Ortiz D, Bedoya G, Mathews C, Davanzo P, Fournier E, Bejarano J, Ramirez M, Araya Ortiz C, Araya X, Molina J, Sabatti C, Reus V, Ospina J, Macaya G, Ruiz-Linares A, Freimer NB. A narrow and highly significant linkage signal for severe bipolar disorder in the chromosome 5q33 region in Latin American pedigrees. Am J Med Genet B Neuropsychiatr Genet. 2009 Oct 5; 150B(7):998-1006.
        View in: PubMed
      14. Wolkowitz OM, Burke H, Epel ES, Reus VI. Glucocorticoids. Mood, memory, and mechanisms. Ann N Y Acad Sci. 2009 Oct; 1179:19-40.
        View in: PubMed
      15. Lawhon D, Humfleet GL, Hall SM, Muñoz RF, Reus VI. Longitudinal analysis of abstinence-specific social support and smoking cessation. Health Psychol. 2009 Jul; 28(4):465-72.
        View in: PubMed
      16. Dhabhar FS, Burke HM, Epel ES, Mellon SH, Rosser R, Reus VI, Wolkowitz OM. Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression. J Psychiatr Res. 2009 Jul; 43(11):962-9.
        View in: PubMed
      17. Hall SM, Humfleet GL, Muñoz RF, Reus VI, Robbins JA, Prochaska JJ. Extended treatment of older cigarette smokers. Addiction. 2009 Jun; 104(6):1043-52.
        View in: PubMed
      18. Peters EJ, Reus V, Hamilton SP. The ABCB1 transporter gene and antidepressant response. F1000 Biol Rep. 2009; 1:23.
        View in: PubMed
      19. Maninger N, Wolkowitz OM, Reus VI, Epel ES, Mellon SH. Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol. 2009 Jan; 30(1):65-91.
        View in: PubMed
      20. Nides M, Glover ED, Reus VI, Christen AG, Make BJ, Billing CB, Williams KE. Varenicline versus bupropion SR or placebo for smoking cessation: a pooled analysis. Am J Health Behav. 2008 Nov-Dec; 32(6):664-75.
        View in: PubMed
      21. Reus VI, Smith BJ. Multimodal techniques for smoking cessation: a review of their efficacy and utilisation and clinical practice guidelines. Int J Clin Pract. 2008 Nov; 62(11):1753-68.
        View in: PubMed
      22. Prochaska JJ, Hall SM, Humfleet G, Munoz RF, Reus V, Gorecki J, Hu D. Physical activity as a strategy for maintaining tobacco abstinence: a randomized trial. Prev Med. 2008 Aug; 47(2):215-20.
        View in: PubMed
      23. Faulkner LR, Tivnan PW, Winstead DK, Reus VI, Andrade NN, Brooks BA, Colenda CC, Mrazek DA, Reifler BV, Schneidman B. The ABPN Maintenance of Certification Program for psychiatrists: past history, current status, and future directions. Acad Psychiatry. 2008 May-Jun; 32(3):241-8.
        View in: PubMed
      24. Hall SM, Humfleet GL, Gorecki JA, Muñoz RF, Reus VI, Prochaska JJ. Older versus younger treatment-seeking smokers: differences in smoking behavior, drug and alcohol use, and psychosocial and physical functioning. Nicotine Tob Res. 2008 Mar; 10(3):463-70.
        View in: PubMed
      25. Chavira DA, Garrido H, Bagnarello M, Azzam A, Reus VI, Mathews CA. A comparative study of obsessive-compulsive disorder in Costa Rica and the United States. Depress Anxiety. 2008; 25(7):609-19.
        View in: PubMed
      26. Mooney ME, Reus VI, Gorecki J, Hall SM, Humfleet GL, Muñoz RF, Delucchi K. Therapeutic drug monitoring of nortriptyline in smoking cessation: a multistudy analysis. Clin Pharmacol Ther. 2008 Mar; 83(3):436-42.
        View in: PubMed
      27. Hall SM, Gorecki JA, Reus VI, Humfleet GL, Muñoz RF. Belief about drug assignment and abstinence in treatment of cigarette smoking using nortriptyline. Nicotine Tob Res. 2007 Apr; 9(4):467-71.
        View in: PubMed
      28. Mathews CA, Nievergelt CM, Azzam A, Garrido H, Chavira DA, Wessel J, Bagnarello M, Reus VI, Schork NJ. Heritability and clinical features of multigenerational families with obsessive-compulsive disorder and hoarding. Am J Med Genet B Neuropsychiatr Genet. 2007 Mar 5; 144B(2):174-82.
        View in: PubMed
      29. Giacomini KM, Brett CM, Altman RB, Benowitz NL, Dolan ME, Flockhart DA, Johnson JA, Hayes DF, Klein T, Krauss RM, Kroetz DL, McLeod HL, Nguyen AT, Ratain MJ, Relling MV, Reus V, Roden DM, Schaefer CA, Shuldiner AR, Skaar T, Tantisira K, Tyndale RF, Wang L, Weinshilboum RM, Weiss ST, Zineh I. The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin Pharmacol Ther. 2007 Mar; 81(3):328-45.
        View in: PubMed
      30. Reus VI, Obach RS, Coe JW, Faessel H, Rollema H, Watsky E, Reeves K. Varenicline: new treatment with efficacy in smoking cessation. Drugs Today (Barc). 2007 Feb; 43(2):65-75.
        View in: PubMed
      31. Keen-Kim D, Mathews CA, Reus VI, Lowe TL, Herrera LD, Budman CL, Gross-Tsur V, Pulver AE, Bruun RD, Erenberg G, Naarden A, Sabatti C, Freimer NB. Overrepresentation of rare variants in a specific ethnic group may confuse interpretation of association analyses. Hum Mol Genet. 2006 Nov 15; 15(22):3324-8.
        View in: PubMed
      32. Herzberg I, Jasinska A, García J, Jawaheer D, Service S, Kremeyer B, Duque C, Parra MV, Vega J, Ortiz D, Carvajal L, Polanco G, Restrepo GJ, López C, Palacio C, Levinson M, Aldana I, Mathews C, Davanzo P, Molina J, Fournier E, Bejarano J, Ramírez M, Ortiz CA, Araya X, Sabatti C, Reus V, Macaya G, Bedoya G, Ospina J, Freimer N, Ruiz-Linares A. Convergent linkage evidence from two Latin-American population isolates supports the presence of a susceptibility locus for bipolar disorder in 5q31-34. Hum Mol Genet. 2006 Nov 1; 15(21):3146-53.
        View in: PubMed
      33. Service S, Molina J, Deyoung J, Jawaheer D, Aldana I, Vu T, Araya C, Araya X, Bejarano J, Fournier E, Ramirez M, Mathews CA, Davanzo P, Macaya G, Sandkuijl L, Sabatti C, Reus V, Freimer N. Results of a SNP genome screen in a large Costa Rican pedigree segregating for severe bipolar disorder. Am J Med Genet B Neuropsychiatr Genet. 2006 Jun 5; 141B(4):367-73.
        View in: PubMed
      34. Mathews CA, Bimson B, Lowe TL, Herrera LD, Budman CL, Erenberg G, Naarden A, Bruun RD, Freimer NB, Reus VI. Association between maternal smoking and increased symptom severity in Tourette's syndrome. Am J Psychiatry. 2006 Jun; 163(6):1066-73.
        View in: PubMed
      35. Harris DS, Reus VI, Wolkowitz O, Jacob P, Everhart ET, Wilson M, Mendelson JE, Jones RT. Catecholamine response to methamphetamine is related to glucocorticoid levels but not to pleasurable subjective response. Pharmacopsychiatry. 2006 May; 39(3):100-8.
        View in: PubMed
      36. Mathews CA, Jang KL, Herrera LD, Lowe TL, Budman CL, Erenberg G, Naarden A, Bruun RD, Schork NJ, Freimer NB, Reus VI. Tic symptom profiles in subjects with Tourette Syndrome from two genetically isolated populations. Biol Psychiatry. 2007 Feb 1; 61(3):292-300.
        View in: PubMed
      37. Glatt CE, Carlson E, Taylor TR, Risch N, Reus VI, Schaefer CA. Response to Zhang et al. (2005): loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45, 11-16. Neuron. 2005 Dec 8; 48(5):704-5; author reply 705-6.
        View in: PubMed
      38. Hall SM, Lightwood JM, Humfleet GL, Bostrom A, Reus VI, Muñoz R. Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation. J Behav Health Serv Res. 2005 Oct-Dec; 32(4):381-92.
        View in: PubMed
      39. Humfleet GL, Prochaska JJ, Mengis M, Cullen J, Muñoz R, Reus V, Hall SM. Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure. Nicotine Tob Res. 2005 Jun; 7(3):453-60.
        View in: PubMed
      40. Harris DS, Reus VI, Wolkowitz OM, Mendelson JE, Jones RT. Repeated psychological stress testing in stimulant-dependent patients. Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jun; 29(5):669-77.
        View in: PubMed
      41. Hall SM, Humfleet GL, Reus VI, Muñoz RF, Cullen J. Extended nortriptyline and psychological treatment for cigarette smoking. Am J Psychiatry. 2004 Nov; 161(11):2100-7.
        View in: PubMed
      42. Mathews CA, Waller J, Glidden D, Lowe TL, Herrera LD, Budman CL, Erenberg G, Naarden A, Bruun RD, Freimer NB, Reus VI. Self injurious behaviour in Tourette syndrome: correlates with impulsivity and impulse control. J Neurol Neurosurg Psychiatry. 2004 Aug; 75(8):1149-55.
        View in: PubMed
      43. Haas AL, Muñoz RF, Humfleet GL, Reus VI, Hall SM. Influences of mood, depression history, and treatment modality on outcomes in smoking cessation. J Consult Clin Psychol. 2004 Aug; 72(4):563-70.
        View in: PubMed
      44. Bearden CE, Reus VI, Freimer NB. Why genetic investigation of psychiatric disorders is so difficult. Curr Opin Genet Dev. 2004 Jun; 14(3):280-6.
        View in: PubMed
      45. Meieran SE, Reus VI, Webster R, Shafton R, Wolkowitz OM. Chronic pregnenolone effects in normal humans: attenuation of benzodiazepine-induced sedation. Psychoneuroendocrinology. 2004 May; 29(4):486-500.
        View in: PubMed
      46. Mathews CA, Reus VI, Bejarano J, Escamilla MA, Fournier E, Herrera LD, Lowe TL, McInnes LA, Molina J, Ophoff RA, Raventos H, Sandkuijl LA, Service SK, Spesny M, León PE, Freimer NB. Genetic studies of neuropsychiatric disorders in Costa Rica: a model for the use of isolated populations. Psychiatr Genet. 2004 Mar; 14(1):13-23.
        View in: PubMed
      47. Hong KS, McInnes LA, Service SK, Song T, Lucas J, Silva S, Fournier E, León P, Molina J, Reus VI, Sandkuijl LA, Freimer NB. Genetic mapping using haplotype and model-free linkage analysis supports previous evidence for a locus predisposing to severe bipolar disorder at 5q31-33. Am J Med Genet B Neuropsychiatr Genet. 2004 Feb 15; 125B(1):83-6.
        View in: PubMed
      48. Ormiston T, Wolkowitz OM, Reus VI, Johnson R, Manfredi F. Hormonal changes with cholesterol reduction: a double-blind pilot study. J Clin Pharm Ther. 2004 Feb; 29(1):71-3.
        View in: PubMed
      49. Mathews CA, Reus VI. Genetic linkage in bipolar disorder. CNS Spectr. 2003 Dec; 8(12):891-904.
        View in: PubMed
      50. Glatt CE, Reus VI. Pharmacogenetics of monoamine transporters. Pharmacogenomics. 2003 Sep; 4(5):583-96.
        View in: PubMed
      51. Ormiston T, Wolkowitz OM, Reus VI, Manfredi F. Behavioral implications of lowering cholesterol levels: a double-blind pilot study. Psychosomatics. 2003 Sep-Oct; 44(5):412-4.
        View in: PubMed
      52. Wolkowitz OM, Reus VI. Neurotransmitters, neurosteroids and neurotrophins: new models of the pathophysiology and treatment of depression. World J Biol Psychiatry. 2003 Jul; 4(3):98-102.
        View in: PubMed
      53. Harris DS, Reus VI, Wolkowitz OM, Mendelson JE, Jones RT. Altering cortisol level does not change the pleasurable effects of methamphetamine in humans. Neuropsychopharmacology. 2003 Sep; 28(9):1677-84.
        View in: PubMed
      54. Segurado R, Detera-Wadleigh SD, Levinson DF, Lewis CM, Gill M, Nurnberger JI, Craddock N, DePaulo JR, Baron M, Gershon ES, Ekholm J, Cichon S, Turecki G, Claes S, Kelsoe JR, Schofield PR, Badenhop RF, Morissette J, Coon H, Blackwood D, McInnes LA, Foroud T, Edenberg HJ, Reich T, Rice JP, Goate A, McInnis MG, McMahon FJ, Badner JA, Goldin LR, Bennett P, Willour VL, Zandi PP, Liu J, Gilliam C, Juo SH, Berrettini WH, Yoshikawa T, Peltonen L, Lönnqvist J, Nöthen MM, Schumacher J, Windemuth C, Rietschel M, Propping P, Maier W, Alda M, Grof P, Rouleau GA, Del-Favero J, Van Broeckhoven C, Mendlewicz J, Adolfsson R, Spence MA, Luebbert H, Adams LJ, Donald JA, Mitchell PB, Barden N, Shink E, Byerley W, Muir W, Visscher PM, Macgregor S, Gurling H, Kalsi G, McQuillin A, Escamilla MA, Reus VI, Leon P, Freimer NB, Ewald H, Kruse TA, Mors O, Radhakrishna U, Blouin JL, Antonarakis SE, Akarsu N. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet. 2003 Jul; 73(1):49-62.
        View in: PubMed
      55. Wolkowitz OM, Kramer JH, Reus VI, Costa MM, Yaffe K, Walton P, Raskind M, Peskind E, Newhouse P, Sack D, De Souza E, Sadowsky C, Roberts E. DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled study. Neurology. 2003 Apr 8; 60(7):1071-6.
        View in: PubMed
      56. Seeley WW, Turetsky N, Reus VI, Wolkowitz OM. Benzodiazepines in schizophrenia: prefrontal cortex atrophy predicts clinical response to alprazolam augmentation. World J Biol Psychiatry. 2002 Oct; 3(4):221-4.
        View in: PubMed
      57. Hall SM, Humfleet GL, Reus VI, Muñoz RF, Hartz DT, Maude-Griffin R. Psychological intervention and antidepressant treatment in smoking cessation. Arch Gen Psychiatry. 2002 Oct; 59(10):930-6.
        View in: PubMed
      58. Escamilla MA, Batki S, Reus VI, Spesny M, Molina J, Service S, Vinogradov S, Neylan T, Mathews C, Meza L, Gallegos A, Montero AP, Cruz ML, Neuhaus J, Roche E, Smith L, Leon P, Freimer NB. Comorbidity of bipolar disorder and substance abuse in Costa Rica: pedigree- and population-based studies. J Affect Disord. 2002 Sep; 71(1-3):71-83.
        View in: PubMed
      59. Ophoff RA, Escamilla MA, Service SK, Spesny M, Meshi DB, Poon W, Molina J, Fournier E, Gallegos A, Mathews C, Neylan T, Batki SL, Roche E, Ramirez M, Silva S, De Mille MC, Dong P, Leon PE, Reus VI, Sandkuijl LA, Freimer NB. Genomewide linkage disequilibrium mapping of severe bipolar disorder in a population isolate. Am J Hum Genet. 2002 Sep; 71(3):565-74.
        View in: PubMed
      60. Marco EJ, Wolkowitz OM, Vinogradov S, Poole JH, Lichtmacher J, Reus VI. Double-blind antiglucocorticoid treatment in schizophrenia and schizoaffective disorder: a pilot study. World J Biol Psychiatry. 2002 Jul; 3(3):156-61.
        View in: PubMed
      61. Reus VI, Wolkowitz OM. Antiglucocorticoid drugs in the treatment of depression. Expert Opin Investig Drugs. 2001 Oct; 10(10):1789-96.
        View in: PubMed
      62. McInnes LA, Service SK, Reus VI, Barnes G, Charlat O, Jawahar S, Lewitzky S, Yang Q, Duong Q, Spesny M, Araya C, Araya X, Gallegos A, Meza L, Molina J, Ramirez R, Mendez R, Silva S, Fournier E, Batki SL, Mathews CA, Neylan T, Glatt CE, Escamilla MA, Luo D, Gajiwala P, Song T, Crook S, Nguyen JB, Roche E, Meyer JM, Leon P, Sandkuijl LA, Freimer NB, Chen H. Fine-scale mapping of a locus for severe bipolar mood disorder on chromosome 18p11.3 in the Costa Rican population. Proc Natl Acad Sci U S A. 2001 Sep 25; 98(20):11485-90.
        View in: PubMed
      63. Neylan TC, Canick JD, Hall SE, Reus VI, Sapolsky RM, Wolkowitz OM. Cortisol levels predict cognitive impairment induced by electroconvulsive therapy. Biol Psychiatry. 2001 Sep 1; 50(5):331-6.
        View in: PubMed
      64. Wolkowitz OM, Epel ES, Reus VI. Stress hormone-related psychopathology: pathophysiological and treatment implications. World J Biol Psychiatry. 2001 Jul; 2(3):115-43.
        View in: PubMed
      65. Mathews CA, Reus VI. Assortative mating in the affective disorders: a systematic review and meta-analysis. Compr Psychiatry. 2001 Jul-Aug; 42(4):257-62.
        View in: PubMed
      66. Harris DS, Wolkowitz OM, Reus VI. Movement disorder, memory, psychiatric symptoms and serum DHEA levels in schizophrenic and schizoaffective patients. World J Biol Psychiatry. 2001 Apr; 2(2):99-102.
        View in: PubMed
      67. Mathews CA, Herrera Amighetti LD, Lowe TL, van de Wetering BJ, Freimer NB, Reus VI. Cultural influences on diagnosis and perception of Tourette syndrome in Costa Rica. J Am Acad Child Adolesc Psychiatry. 2001 Apr; 40(4):456-63.
        View in: PubMed
      68. Escamilla MA, McInnes LA, Service SK, Spesny M, Reus VI, Molina J, Gallegos A, Fournier E, Batki S, Neylan T, Matthews C, Vinogradov S, Roche E, Tyler DJ, Shimayoshi N, Mendez R, Ramirez R, Ramirez M, Araya C, Araya X, Leon PE, Sandkuijl LA, Freimer NB. Genome screening for linkage disequilibrium in a Costa Rican sample of patients with bipolar-I disorder: a follow-up study on chromosome 18. Am J Med Genet. 2001 Mar 8; 105(2):207-13.
        View in: PubMed
      69. Piva JR, Ortega HH, Canal AM, Piva CE, Reus V, Seib EP. [Identification of fungi in tissues and cultures: the importance of argirophilic substances on its cellular walls]. Rev Fac Cien Med Univ Nac Cordoba. 2001; 58(1):57-64.
        View in: PubMed
      70. Ospina-Duque J, Duque C, Carvajal-Carmona L, Ortiz-Barrientos D, Soto I, Pineda N, Cuartas M, Calle J, Lopez C, Ochoa L, Garcia J, Gomez J, Agudelo A, Lozano M, Montoya G, Ospina A, Lopez M, Gallo A, Miranda A, Serna L, Montoya P, Palacio C, Bedoya G, McCarthy M, Reus V, Freimer N, Ruiz-Linares A. An association study of bipolar mood disorder (type I) with the 5-HTTLPR serotonin transporter polymorphism in a human population isolate from Colombia. Neurosci Lett. 2000 Oct 13; 292(3):199-202.
        View in: PubMed
      71. Reus VI, Rawitscher L. Possible interaction of tramadol and antidepressants. Am J Psychiatry. 2000 May; 157(5):839.
        View in: PubMed
      72. Tsoh JY, Humfleet GL, Muñoz RF, Reus VI, Hartz DT, Hall SM. Development of major depression after treatment for smoking cessation. Am J Psychiatry. 2000 Mar; 157(3):368-74.
        View in: PubMed
      73. Wolkowitz OM, Reus VI. Treatment of depression with antiglucocorticoid drugs. Psychosom Med. 1999 Sep-Oct; 61(5):698-711.
        View in: PubMed
      74. Costa MM, Reus VI, Wolkowitz OM, Manfredi F, Lieberman M. Estrogen replacement therapy and cognitive decline in memory-impaired post-menopausal women. Biol Psychiatry. 1999 Jul 15; 46(2):182-8.
        View in: PubMed
      75. Escamilla MA, McInnes LA, Spesny M, Reus VI, Service SK, Shimayoshi N, Tyler DJ, Silva S, Molina J, Gallegos A, Meza L, Cruz ML, Batki S, Vinogradov S, Neylan T, Nguyen JB, Fournier E, Araya C, Barondes SH, Leon P, Sandkuijl LA, Freimer NB. Assessing the feasibility of linkage disequilibrium methods for mapping complex traits: an initial screen for bipolar disorder loci on chromosome 18. Am J Hum Genet. 1999 Jun; 64(6):1670-8.
        View in: PubMed
      76. Yaffe K, Blackwell T, Gore R, Sands L, Reus V, Browner WS. Depressive symptoms and cognitive decline in nondemented elderly women: a prospective study. Arch Gen Psychiatry. 1999 May; 56(5):425-30.
        View in: PubMed
      77. Wolkowitz OM, Reus VI, Chan T, Manfredi F, Raum W, Johnson R, Canick J. Antiglucocorticoid treatment of depression: double-blind ketoconazole. Biol Psychiatry. 1999 Apr 15; 45(8):1070-4.
        View in: PubMed
      78. Wolkowitz OM, Reus VI, Keebler A, Nelson N, Friedland M, Brizendine L, Roberts E. Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry. 1999 Apr; 156(4):646-9.
        View in: PubMed
      79. Humfleet G, Muñoz R, Sees K, Reus V, Hall S. History of alcohol or drug problems, current use of alcohol or marijuana, and success in quitting smoking. Addict Behav. 1999 Jan-Feb; 24(1):149-54.
        View in: PubMed
      80. Hall SM, Reus VI, Muñoz RF, Sees KL, Humfleet G, Hartz DT, Frederick S, Triffleman E. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry. 1998 Aug; 55(8):683-90.
        View in: PubMed
      81. McInnes LA, Reus VI, Freimer NB. Mapping genes for psychiatric disorders and behavioral traits. Curr Opin Genet Dev. 1998 Jun; 8(3):287-92.
        View in: PubMed
      82. Frederick SL, Reus VI, Ginsberg D, Hall SM, Munoz RF, Ellman G. Cortisol and response to dexamethasone as predictors of withdrawal distress and abstinence success in smokers. Biol Psychiatry. 1998 Apr 1; 43(7):525-30.
        View in: PubMed
      83. Knutson B, Wolkowitz OM, Cole SW, Chan T, Moore EA, Johnson RC, Terpstra J, Turner RA, Reus VI. Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry. 1998 Mar; 155(3):373-9.
        View in: PubMed
      84. Wolkowitz OM, Reus VI, Canick J, Levin B, Lupien S. Glucocorticoid medication, memory and steroid psychosis in medical illness. Ann N Y Acad Sci. 1997 Aug 14; 823:81-96.
        View in: PubMed
      85. Reus VI, Freimer NB. Understanding the genetic basis of mood disorders: where do we stand? Am J Hum Genet. 1997 Jun; 60(6):1283-8.
        View in: PubMed
      86. Reus VI. Olanzapine: a novel atypical neuroleptic agent. Lancet. 1997 May 3; 349(9061):1264-5.
        View in: PubMed
      87. Wolkowitz OM, Reus VI, Roberts E, Manfredi F, Chan T, Raum WJ, Ormiston S, Johnson R, Canick J, Brizendine L, Weingartner H. Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry. 1997 Feb 1; 41(3):311-8.
        View in: PubMed
      88. Knutson B, Cole S, Wolkowitz O, Reus V, Chan T, Moore E. Serotonergic intervention increases affiliative behavior in humans. Ann N Y Acad Sci. 1997 Jan 15; 807:492-3.
        View in: PubMed
      89. Reus VI, Wolkowitz OM, Frederick S. Antiglucocorticoid treatments in psychiatry. Psychoneuroendocrinology. 1997; 22 Suppl 1:S121-4.
        View in: PubMed
      90. McInnes LA, Escamilla MA, Service SK, Reus VI, Leon P, Silva S, Rojas E, Spesny M, Baharloo S, Blankenship K, Peterson A, Tyler D, Shimayoshi N, Tobey C, Batki S, Vinogradov S, Meza L, Gallegos A, Fournier E, Smith LB, Barondes SH, Sandkuijl LA, Freimer NB. A complete genome screen for genes predisposing to severe bipolar disorder in two Costa Rican pedigrees. Proc Natl Acad Sci U S A. 1996 Nov 12; 93(23):13060-5.
        View in: PubMed
      91. Hall SM, Muñoz RF, Reus VI, Sees KL, Duncan C, Humfleet GL, Hartz DT. Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study. J Consult Clin Psychol. 1996 Oct; 64(5):1003-9.
        View in: PubMed
      92. Wolkowitz OM, Reus VI, Manfredi F, Chan T, Ormiston S, Johnson R. Dexamethasone for depression. Am J Psychiatry. 1996 Aug; 153(8):1112; author reply 1112-3.
        View in: PubMed
      93. Smith LB, Sapers B, Reus VI, Freimer NB. Attitudes towards bipolar disorder and predictive genetic testing among patients and providers. J Med Genet. 1996 Jul; 33(7):544-9.
        View in: PubMed
      94. Reus VI. Management of treatment-resistant unipolar and chronically depressed patients. Psychiatr Clin North Am. 1996 Jun; 19(2):201-13.
        View in: PubMed
      95. Freimer NB, Reus VI, Escamilla M, Spesny M, Smith L, Service S, Gallegos A, Meza L, Batki S, Vinogradov S, Leon P, Sandkuijl LA. An approach to investigating linkage for bipolar disorder using large Costa Rican pedigrees. Am J Med Genet. 1996 May 31; 67(3):254-63.
        View in: PubMed
      96. Escamilla MA, Spesny M, Reus VI, Gallegos A, Meza L, Molina J, Sandkuijl LA, Fournier E, Leon PE, Smith LB, Freimer NB. Use of linkage disequilibrium approaches to map genes for bipolar disorder in the Costa Rican population. Am J Med Genet. 1996 May 31; 67(3):244-53.
        View in: PubMed
      97. Freimer NB, Reus VI, Escamilla MA, McInnes LA, Spesny M, Leon P, Service SK, Smith LB, Silva S, Rojas E, Gallegos A, Meza L, Fournier E, Baharloo S, Blankenship K, Tyler DJ, Batki S, Vinogradov S, Weissenbach J, Barondes SH, Sandkuijl LA. Genetic mapping using haplotype, association and linkage methods suggests a locus for severe bipolar disorder (BPI) at 18q22-q23. Nat Genet. 1996 Apr; 12(4):436-41.
        View in: PubMed
      98. Reus VI. Psychiatry. West J Med. 1996 Mar; 164(3):256.
        View in: PubMed
      99. Reus VI. Magnetic resonance spectroscopy and psychiatry. West J Med. 1996 Mar; 164(3):256-7.
        View in: PubMed
      100. Reus VI. Behavioral genetics. West J Med. 1996 Mar; 164(3):260.
        View in: PubMed
      101. Wolkowitz OM, Reus VI, Roberts E, Manfredi F, Chan T, Ormiston S, Johnson R, Canick J, Brizendine L, Weingartner H. Antidepressant and cognition-enhancing effects of DHEA in major depression. Ann N Y Acad Sci. 1995 Dec 29; 774:337-9.
        View in: PubMed
      102. Hall SM, Muñoz RF, Reus VI. Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. J Consult Clin Psychol. 1994 Feb; 62(1):141-6.
        View in: PubMed
      103. Reus VI. Are stress hormones and serotonin related to aggression in primates? Arch Gen Psychiatry. 1994 Jan; 51(1):72-3.
        View in: PubMed
      104. Reus VI. Mind and brain. Science. 1993 Dec 10; 262(5140):1629.
        View in: PubMed
      105. Hall SM, Muñoz RF, Reus VI, Sees KL. Nicotine, negative affect, and depression. J Consult Clin Psychol. 1993 Oct; 61(5):761-7.
        View in: PubMed
      106. Reus VI. Rational polypharmacy in the treatment of mood disorders. Ann Clin Psychiatry. 1993 Jun; 5(2):91-100.
        View in: PubMed
      107. Wolkowitz OM, Weingartner H, Rubinow DR, Jimerson D, Kling M, Berretini W, Thompson K, Breier A, Doran A, Reus VI, et al. Steroid modulation of human memory: biochemical correlates. Biol Psychiatry. 1993 May 15; 33(10):744-6.
        View in: PubMed
      108. Wolkowitz OM, Reus VI, Manfredi F, Ingbar J, Brizendine L, Weingartner H. Ketoconazole administration in hypercortisolemic depression. Am J Psychiatry. 1993 May; 150(5):810-2.
        View in: PubMed
      109. Wolkowitz OM, Reus VI, Manfredi F, Ingbar J, Brizendine L. Antiglucocorticoid strategies in hypercortisolemic states. Psychopharmacol Bull. 1992; 28(3):247-51.
        View in: PubMed
      110. Wolkowitz OM, Turetsky N, Reus VI, Hargreaves WA. Benzodiazepine augmentation of neuroleptics in treatment-resistant schizophrenia. Psychopharmacol Bull. 1992; 28(3):291-5.
        View in: PubMed
      111. Deicken RF, Reus VI, Manfredi L, Wolkowitz OM. MRI deep white matter hyperintensity in a psychiatric population. Biol Psychiatry. 1991 May 1; 29(9):918-22.
        View in: PubMed
      112. Wolkowitz OM, Reus VI, Weingartner H, Thompson K, Breier A, Doran A, Rubinow D, Pickar D. Cognitive effects of corticosteroids. Am J Psychiatry. 1990 Oct; 147(10):1297-303.
        View in: PubMed
      113. Demitrack MA, Lewy AJ, Reus VI. Pineal-adrenal interactions: the effect of acute pharmacological blockade of nocturnal melatonin secretion. Psychiatry Res. 1990 May; 32(2):183-9.
        View in: PubMed
      114. Hall SM, Munoz R, Reus V. Smoking cessation, depression and dysphoria. NIDA Res Monogr. 1990; 105:312-3.
        View in: PubMed
      115. Reus VI. Behavioral aspects of thyroid disease in women. Psychiatr Clin North Am. 1989 Mar; 12(1):153-65.
        View in: PubMed
      116. Reus VI. Genetics of mental illness. West J Med. 1987 Jul; 147(1):77-8.
        View in: PubMed
      117. Hargreaves WA, Zachary R, LeGoullon M, Binder R, Reus V. Neuroleptic dose: a statistical model for analyzing historical trends. J Psychiatr Res. 1987; 21(3):199-214.
        View in: PubMed
      118. Peeke HV, Ellman G, Dark K, Salfi M, Reus VI. Cortisol and behaviorally conditioned histamine release. Ann N Y Acad Sci. 1987; 496:583-7.
        View in: PubMed
      119. Zetin M, Garber D, De Antonio M, Schlegel A, Feureisen S, Fieve R, Jewett C, Reus V, Huey LY. Prediction of lithium dose: a mathematical alternative to the test-dose method. J Clin Psychiatry. 1986 Apr; 47(4):175-8.
        View in: PubMed
      120. Reus VI. Behavioral disturbances associated with endocrine disorders. Annu Rev Med. 1986; 37:205-14.
        View in: PubMed
      121. Reus VI. A neuroanatomic perspective on state-dependent learning: the role of the striatum. Acta Neurol Scand Suppl. 1986; 109:31-6.
        View in: PubMed
      122. Reus VI, Peeke HV, Miner C. Habituation and cortisol dysregulation in depression. Biol Psychiatry. 1985 Sep; 20(9):980-9.
        View in: PubMed
      123. Uhl V, Reus VI, Fromm JB. Psychiatric symptoms in Behçet's syndrome. Psychosomatics. 1985 Jun; 26(6):547-9.
        View in: PubMed
      124. Reus VI. Toward an understanding of cortisol dysregulation in major depression: a review of studies of the dexamethasone suppression test and urinary free-cortisol. Psychiatr Med. 1985; 3(1):1-21.
        View in: PubMed
      125. Post RM, Rubinow DR, Uhde TW, Ballenger JC, Lake CR, Linnoila M, Jimerson DC, Reus V. Effects of carbamazepine on noradrenergic mechanisms in affectively ill patients. Psychopharmacology (Berl). 1985; 87(1):59-63.
        View in: PubMed
      126. Reus VI, Miner C. Evidence for physiological effects of hypercortisolemia in psychiatric patients. Psychiatry Res. 1985 Jan; 14(1):47-56.
        View in: PubMed
      127. Peeke S, Halliday R, Callaway E, Prael R, Reus V. Effects of two doses of methylphenidate on verbal information processing in hyperactive children. J Clin Psychopharmacol. 1984 Apr; 4(2):82-8.
        View in: PubMed
      128. Dark KA, Ellman G, Peeke HV, Galin D, Reus VI. Sex differences and asymmetries of catecholamines: relation to turning preferences. Pharmacol Biochem Behav. 1984 Mar; 20(3):327-30.
        View in: PubMed
      129. Joseph MS, Brewerton TD, Reus VI, Stebbins GT. Plasma L-tryptophan/neutral amino acid ratio and dexamethasone suppression in depression. Psychiatry Res. 1984 Mar; 11(3):185-92.
        View in: PubMed
      130. Grebb JA, Yingling CD, Reus VI. Electrophysiologic abnormalities in patients with eating disorders. Compr Psychiatry. 1984 Mar-Apr; 25(2):216-24.
        View in: PubMed
      131. Reus VI. Cognitive changes in schizoaffective patients. Arch Gen Psychiatry. 1983 Nov; 40(11):1255.
        View in: PubMed
      132. Reus VI, Joseph M, Dallman M. Regulation of ACTH and cortisol in depression. Peptides. 1983 Sep-Oct; 4(5):785-8.
        View in: PubMed
      133. Brewerton TD, Reus VI. Lithium carbonate and L-tryptophan in the treatment of bipolar and schizoaffective disorders. Am J Psychiatry. 1983 Jun; 140(6):757-60.
        View in: PubMed
      134. Reus VI. Hyperthyroidism may affect dexamethasone suppression. J Clin Psychopharmacol. 1983 Jun; 3(3):203.
        View in: PubMed
      135. Jimerson DC, Insel TR, Reus VI, Kopin IJ. Increased plasma MHPG in dexamethasone-resistant depressed patients. Arch Gen Psychiatry. 1983 Feb; 40(2):173-6.
        View in: PubMed
      136. Norman KP, Cerrone KL, Reus VI. Renal lithium clearance as a rapid and accurate predictor of maintenance dose. Am J Psychiatry. 1982 Dec; 139(12):1625-6.
        View in: PubMed
      137. Callaway E, Halliday R, Peeke S, Reus V. How does methylphenidate (MP) affect information processing in man? Psychopharmacol Bull. 1982 Oct; 18(4):205-6.
        View in: PubMed
      138. Ballenger JC, Reus VI, Post RM. The "atypical" clinical picture of adolescent mania. Am J Psychiatry. 1982 May; 139(5):602-6.
        View in: PubMed
      139. Reus VI. Pituitary-adrenal disinhibition as the independent variable in the assessment of behavioral symptoms. Biol Psychiatry. 1982 Mar; 17(3):317-26.
        View in: PubMed
      140. Reus VI, Joseph MS, Dallman MF. ACTH levels after the dexamethasone suppression test in depression. N Engl J Med. 1982 Jan 28; 306(4):238-9.
        View in: PubMed
      141. Buchsbaum MS, Reus VI, Davis GC, Holcomb HH, Cappelletti J, Silberman E. Role of opioid peptides in disorders of attention in psychopathology. Ann N Y Acad Sci. 1982; 398:352-65.
        View in: PubMed
      142. Silberman EK, Reus VI, Jimerson DC, Lynott AM, Post RM. Heterogeneity of amphetamine response in depressed patients. Am J Psychiatry. 1981 Oct; 138(10):1302-7.
        View in: PubMed
      143. Reus VI. Psychiatry-epitomes of progress: screening for endogenous depression: the dexamethasone suppression test. West J Med. 1981 Feb; 134(2):143.
        View in: PubMed
      144. Davis GC, Extein I, Reus VI, Hamilton W, Post RM, Goodwin FK, Bunney WE. Failure of naloxone to reduce manic symptoms. Am J Psychiatry. 1980 Dec; 137(12):1583-5.
        View in: PubMed
      145. Reus VI. Neuropeptide modulation of opiate and ethanol tolerance and dependence. Med Hypotheses. 1980 Nov; 6(11):1141-8.
        View in: PubMed
      146. Reus VI, Lake CR, Post RM. Effect of piribedil (ET-495) on plasma norepinephrine: relationship to antidepressant response. Commun Psychopharmacol. 1980; 4(3):207-13.
        View in: PubMed
      147. Reus VI, Weingartner H, Post RM. Clinical implications of state-dependent learning. Am J Psychiatry. 1979 Jul; 136(7):927-31.
        View in: PubMed
      148. Reus VI. Behavioral side effects of medical drugs. Prim Care. 1979 Jun; 6(2):283-94.
        View in: PubMed
      149. Reus VI, Targum SD, Weingarter H, Post RM. Effect of lithium carbonate on memory processes of bipolar affectively ill patients. Psychopharmacology (Berl). 1979 May 8; 63(1):39-42.
        View in: PubMed
      150. Reus VI, Gold P, Post R. Lithium-induced thyrotoxicosis. Am J Psychiatry. 1979 May; 136(5):724-5.
        View in: PubMed
      151. Reus VI, Silberman E, Post RM, Weingartner H. d-Amphetamine: effects on memory in a depressed population. Biol Psychiatry. 1979 Apr; 14(2):345-56.
        View in: PubMed
      152. Gold PW, Goodwin FK, Reus VI. Vasopressin in affective illness. Lancet. 1978 Jun 10; 1(8076):1233-6.
        View in: PubMed
      153. Wilkinson CB, Reus VI. An examination of the federal psychiatric training grant peer review process. Am J Psychiatry. 1977 Jun; 134(6):637-41.
        View in: PubMed
      154. Pardes H, Freedman AM, Reus V. Research training in psychiatry. Am J Psychiatry. 1977 Mar; 134 Suppl:suppl 24-8.
        View in: PubMed
      155. Eaton JS, Haas MR, Abraham AS, Reus VI, Goldberg R. The development of criteria for evaluating psychiatric education programs. Arch Gen Psychiatry. 1976 Apr; 33(4):439-42.
        View in: PubMed
      Victor's Networks
      Click the "See All" links for more information and interactive visualizations!
      Related Concepts
      Derived automatically from this person's publications.
      See all (538) concept(s)
      _
      Co-Authors
      People in Profiles who have published with this person.
      See all (33) people
      _
      Related Authors
      People who share similar concepts with this person.
      See all (60) people
      _
      Same Department
      Search Department
      Back to TOP